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INTRODUCTION 
The insidious spread of Venezuelan equine encephalomyelitis virus 
(VEE) from South America through Central America to the.United States has 
aroused great concern within the horse industry and among agricultural 
officials in the United States. Indeed the disease in the epizoodemic 
form appears to have been eliminated from the continental borders of this 
country but the mechanisms by which this virus can apparently reside 
within a given region are unknown. The term epizoodemic as employed in 
the text above refers to the concurrent presence of an epidemic and an 
epizootic·due to a single disease agent (56,57). There is at present a 
great confusion of terminology in the literature due to the remarkable 
ability of the VEE virus complex to give rise to several forms of disease 
among man, domestic animals, and fauna of the countryside. Therefore, in 
an attempt to reduce this confusion, the term epizoodemic shall be em-
ployed in this study. 
Due to the explosiveness of epizoodemic VEE it has become imperative 
to have rapid diagnostic.techniques available to the virologist for con-
firmation of the disease agent in domestic livestock and in wildlife 
populations. Such a technique is readily available in the form of the 
fluorescent antibody test whf.ch can be used to obtain positive or negative. 
results within a 48 hour period as compared to suckling mouse inoculation. 
with complement fixation (CF) test confirmation which requires from 72 
hours to one week for comp 1 et ion of diagnosis •. 
-' 
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The invasion of the United States by VEE with subsequent eradication 
in 1971 has emphasized the need for a natural sentinel to detect the 
virus should it reenter the country in the future. Several animals have 
been investl'gated as possible sentinels by other workers. These include 
the canine (9), bovine, porcine (33), equine (25), laboratory (39,43,105, 
107,108) and wild ungulate (67) species. Despite such intensive work, the 
suitability of the goat, (Capra hircus), as a sentinel species has not 
been investigated. 
In hypothesizing the means by which epizoodemic strains of VEE run 
rampant through the countryside, reference has occasionally been made to 
the possibility of the goat acting as ,a silent amplifier of the virus 
(57,104,110). ·Jt was the purpose of this. study, firstly, to investigate 
the suitability of the goat as a sentinel for virus activity, and 
secondly, to determine the sensitivity of the fluorescent antibody test 
on cell cultures as compared· to suckling mouse inoculation with con-
firmatory CF test for identification of VEE virus from tissue specimens. 
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REVIEW OF LITERATURE 
History 
An encephalitic disease of equines which appeared in 1935 in the 
river valleys of Huila, Tolima, Valle, and Bolivar in the Andes mountains 
of western Colombia was tentative I y diagnosed as Barna' s disease or 
European equine encephalitis. From there the disease spread to Magdalena, 
Colombia in 1936 and later that year appeared in the Guajira peninsula of 
Colombia and Venezuela ( 125). In 1938 Kubes. and Rios of the Venezuelan 
Ministry of Agriculture and Animal Husbandry isolated a filterable v.irus 
from the brain of a horse that had died with encephalitic signs (77). 
Subsequent characterization of the agent was done by Kubes (76), 
Kubes and R las ( 77) and by Beck and Wyckoff ( 6) in 1939 and 1944. The 
virus was found to be of greater virulence for equidae than any of the 
eastern or western equine encephalomyelitis viru.ses previously ·identified· 
in South America. It also differed immunologically from these viruses. 
Due to its origin the encephalitic agent was designated "Venezuelan equine 
encephalomyel it is virus. 11 A uniform system of nomenclature was not 
available for the complex of endemic (enzootic) and epizoodemic strains 
of Venezuelan equine encephalomyelitis (VEE) virus that later arose 
until Youn,g and Johnson (134) in 1969 published their system embracing 
the antigenic variants of VEE (Table 1). 
Since 1939, either epizoodemics or epidemics of VEE have been 
described in Peru, Ecuador, Columbia, Venezuela, Trinidad, Costa Rica, 
Nicaragua, Honduras, El Salvador, Guatemala, Mexico and the United States. 
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Table 1. Anti gen i c· subtypes of Venezuelan ·equine enceph a 1omye1 it is 
virus (69, 134) 
Antigenic Isolate Origin Epizoodemic 
subtype 
IA Trinidad Tr.inidad, 1943 Yes 
donkey 
IB lea Peru, 1946 Yes 
Pergamlno Argentina, 1958 Yes 
re p676 Venezuela, 1963 Yes 
V198 . Colombia, 1962 Yes 
ID 3880 Eastern 'No 
Panama, 1961 
IE Mena II Western No 
Panama, 1962 
63A216 Mexico, 1963 No 
II Fe3-7c Florida, 1963 No 
III Mucambo Brazil, 1954 No 
Paramaribo Surinam, 1963 No 
52049 Trinidad, 1959 No 
IV Pixuna Brazil, 1961 No 
5 
Endemic foci have also been found to be widely distributed in the western 
hemisphere including Brazil, Trinidad, Surinam, Colombia, Panama, 
Nicaragua, Honduras, Guatemala, British Honduras, Mexico and Florida (57). 
Current virus activity 
In 1969 a severe epizoodemic of VEE arose in Guatemala and eventually 
reached Texas in late June, 1971 (22,24,_37,39,42,56,75,114,124,13P). The 
source of VEE virus for this and other epizoodemics remains an enigma. 
Three possible alternatives for the introduction of the virulent IB 
subtype of VEE virus into Guatemala have recently been proposed by 
Franck and Johnson (42). They are (1) mutation of an endemic virus 
subtype, (2) sudden emergence of a previously silent unrecognized virus, 
and (3) introduction of the virus from another region. Introduction of 
the IB subtype of VEE virus into Guatemala from Ecuador has been suggested 
by several authors (37,42,86,114, 1~9). 
Equine deaths were first reported along the Pacific coast of 
Guatemala near El Salvador and shortly thereafter in northeastern 
El Salvador. VEE then spread north and south from each focus. The 
southward spread of the disease included Honduras (1969), Nicaragua 
(1969), and Costa Rica (1970). Susceptible equines were vaccinated with 
the attenuated TC-83 strain of VEE virus in Guatemala in an attempt to 
halt the northward spread of epizoodemic VEE. However, in August, 1969, 
epizoodemic VEE virus was isolated in the upper Grijalva River Valley 
of Chiapas, Mexico near the Guatemalan border. Equine deaths continued 
through the month of February and increased with the start of the rainy 
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season in June. From there the disease spread westward through the 
mountain canyons to the state,of Oaxaca on the Pacific coast and was 
confined to that region by vaccination until September when the disease 
appeared just outside th'e vaccination zone in the state of Veracruz. 
Vaccination was resumed only to have epizoodemic VEE occur again just 
outside the barrier to the north. 
Extension of the disease followed a similar pattern on the Pacific 
coast as it progressively appeared beyond each new vaccination barrier. 
Epizoodemic VEE had spread northward along the Pacific coast through the 
state of Guerrero to the state of Michoacah by November, 1970. 
Virus activity continued unreported through the end of 1970 and 
into Apri 1 of 1971. Equine deaths were then confirmed· as VEE in Veracruz 
and a new vaccination barrier was established to the no'rth. Despite al 1 
vaccination barriers epizoodemic VEE continued its northward spread across 
salt water lagoons of Mexico's gulf coast some 400 kilometers to Texas 
( 125) • 
First case of epizoodemic VEE in the United States 
The first confirmed case of epizoodemic VEE .in the United States was 
reported on June 23, 1971, near Three Rivers, Five Oak County, Texas, 
approximately 320 kilometers northwest of Brownsville. The Texas 
epizoodemic peaked in the equine population by mid-July (30 virus 
isolations per day) and by the end of July had decreased to fewer than 
5 viral isolates of epizoodemic VEE virus per day. A combination of 
ultra-low-volume aerial insecticide application and vaccination (TC-83 
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virus) of all susceptible equines in Texas effectively brought the in-. 
vasion of Texas' equine and human populations to an end by November 7, 
1971 (75). A total of 1,620 equine deaths and an additional 2,000 
clinical cases of epizoodemic VEE were recorded in Texas in 1971 (86). 
Epizoodemic virus activity in Mexico in 1972 
Confirmed (virus isolation) epizoodemic VEE virus activity recurred 
in Mexico in the states of Durango and Sonora in 1972. Other noncon-
finned reports of VEE outbreaks came from the states of Nayarit, Guerrero, 
and Morelos. Intensification of vaccination of susceptible equines with 
the TC-83 strain of VEE virus in the state of Sonora in addition to that 
done in 1971 appears to have prevented epizoodemic VEE from advancing 
beyond Hermosillo, which is approximately 265 ·kilometers south of the 
Arizona-Mexico border (22,23,24,25). 
Arthropod vectors and their possible role in the spread of epizoodemic VEE 
Epizoodemic strains of VEE have been isolated from at least 25 
species of mosquitoes consisting of 7 genera and one subgenus (22,1151 
125} (Table 2). Isolation of epizoodemic VEE virus from field-trapped 
mosquitoes in itself is insufficient evidence to incriminate a particular· 
species as a vector of the disease. Three additional factors must be 
evaluated prior to the assignment of vector status (115). They are as 
fol lows: 
(1) Determination of the infection threshold and infection rate of 
the mosquito. Infection threshold may be defined as that level 
of host viremia sufficient to infect 1 to 5 percent of the 
mosquitoes feeding upon the virus source. Infection ra.te is 
the percent of mosquitoes that are viremic 14 to 21 days after 
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Table 2. Mosquito species from which epizoodemic VEE viruses have been 
isolated ( 115,117,123,12~ 
Mosquito species 
Aedes aegypti 
Aedes angustivittatus 
Aedes scapularis 
Aedes serratus 
Aedes sollicitans 
Aedes taeniorhynchus 
Aedes thelcter 
Anopheles aquasalis 
Anopheles crucians 
Anopheles neomaculipennis 
Anopheles pseudopunctipennls. 
Anopheles punctimacula 
Cul ex aikeni i 
Culex cor.niger 
Culex niqripalpus 
Culex guinguefasciatus 
Culex (Melanoconion) sp. 
Culiseta inornata 
Deinocerites pseudes 
Mansonia indubitans 
Mansonia tltillans 
Psorophora ciliata 
. Psorophora c i Ii pes 
Psorophora confinn is 
Psorophora discolor 
Country 
Venezue 1 a 
Colombia 
Venezuela 
Venezuela 
Texas, U.S.A. 
Colombia, Venezuela, Costa Rica; 
Texas, U.S.A. 
Texas, U.S.A. 
Venezuela 
Texas, U.S.A. 
Trinidad 
Texas, U.S.A. 
Colombia 
Colombia 
Colombia 
Guatemala 
Colombia 
Guatemala; Texas, U.S.A. 
Mexico 
Costa Rica 
Colombia 
Colombia, Guatemala, Trinidad 
Texas, U.S.A • 
Guatemala 
Venezuela, Guatemala; Texas, U.S.A. 
Texas, U.S.A. 
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having fed upon a viremic host. Infection is determined by 
trituration of each mosquito with subsequent inoculation of 
one 2- to 4-day-old mouse per mosquito. 
(2) Determination of transmission rate of the mosquito. This is 
obtained by allowing individuals one opportunity to infect a 
susceptible host .following an incubation period (14-21 days) 
after the original blood meal. The transmission rate is then 
calculated by determining the percentage of infected individuals 
that transmitted the disease agent. Infection is assayed as 
described ·in (1) after al lowing the arthropod to engorge. 
(3) Determination of the extent of mosquito-host interaction. Field 
studies are employed to define this parameter of the possible 
vector as determined by (1) and (2). Areas of mosquito-host 
interaction usually considered are proximity of the host to 
breeding sites of the mosquito, blood meal identification, 
abundance of the potential vector species, attraction rate to 
various sentinel hosts, longevity, and flight range of the 
mosquito. 
Some information on potential epizoodemic VEE virus vectors has been 
presented (Tables 3 and 4), but much remains to be done. Simulium spp. 
have also been implicated as biologic vectors of VEE virus. However, no 
I aboratory data are avai I ab le to substantiate th is hypothesis (16,7D, 121). 
The average host viremia needed to infect a suitable ~osquito vector 
species with VEE virus is 5.D log1D suckling mouse intracerebral lethal 
dose for 5D% of those inoculated per ml (SMICLD
50
) of viremic ·blood (14, 
16) and an average VEE virus inoculum per mosquito bite has been stated 
1 to be 3.0 log 10 SMICLD50 
For establishment of infection and trans-
mission capability of a mosquito two major barriers must be overcome (17). 
When a mosquito feeds upon a host the blood meal moves directly to the 
glandular midgut for digestion. To retain the blood meal within the 
1chamberlain, R. W., Communicable Disease Center, Atlanta, 
Georgia. Personal communication. October, 1971. 
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Table 3. Mosquito infection and transmission rates for VEE virus IA (74) 
Mosquito species % infected % transmitting 
Cy]ex tarsal is 100 100 
Aedes triseriatus 100 90 
Aedes canadensis 100 50 
Psorophora confinnis 96 45 
Aedes sol 1 lcitans Bo 44 
Aedes aegypti 79 26 
Manson i a tit i 11 ans 56 22 
Anopheles freeborni 90 22 
Mansonia indubltans 72 17 
Anopheles guadrimaculatus 16 4 
Culex pipiens 12 4 
Table 4. Mosquito infection thresholds for VEE virus IB (115) 
Mosquito species 
Psorophora confinnis 
Aedes aegvpti 
Aedes triseriatus 
Aedes taenlorhynchus 
Anopheles guadrimaculatus 
Culex nigripalpus 
% mosquitos 
infected 
2 
3 
2 
4 
0 
0 
Vlremic hosts 
titera 
4.9 - 5.2 
4.9 - 5.2 
6.1 
6.7 - 7.1 
>6.7 - 7.1 
>6.7-7.1 
aSuckling mouse lethal does 50"/o per ml (SML0
50
tml) of viremic blood. 
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digestive tract a peritrophic membrane is usually secreted around it 
which then serves as a minor barrier to passage of virus from a viremic 
blood meal to the midgut epithelial cells. The virus may then attach to 
suitable receptor sites if they are ava.ilable. These represent the first 
major barrier to infection of the mosquito. Assuming the mosquito is a 
suitable host species, the virus adsorbs to the midgut cells and is likely 
taken into the cell by the process of pinocytosis or viropexis. Upon 
entering the cell it is subjected to the action of a series of enzymes 
which uncoat the virion. Replication of the viral nucleic acid and coat 
materials then occurs with eventual assembly and maturation of progeny 
virions. In the process of maturation the assembled viral nuclear mate-
rial is extruded through the cel 1 's cytoplasmic membrane containing 
virus-specified envelope components. Hence, with viral maturation the 
progeny virions pass out of the midgut epithelial cell to enter the 
hemolymph of the mosquito. Having entered the primitive circulatory 
system the virus is then able to infect the organs of the mosquito that 
are bathed by the hemolymph. Viral replication ensues, but appears to 
continue only in the salivary glands. Within the salivary glands the 
virus replicates to high titers where it is considered to persist for 
the lifespan of the mosquito. The second major barrier is now at hand. 
In order for the mosquito to be infective the virus must be able to bud 
out from the acinar cells of the salivary glands into the salivary ducts 
or their precursors. If the mosquito in question is a vector species 
the virus buds into the salivary gland ducts and the mosquito is then 
infective indefinitely according to laboratory studies (16,17). The 
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extrinsic incubation period In the mosquito can be defined as the interval 
required for virus to appear in the salivary juices after feeding upon a 
viremic host. This period is inversely proportional to the ambient 
temperature of the mosquito's habitat. For species of Aedes and 
Mansonia the period is probably no more than 8 to 12 days or about-the 
span of time between the first and the third blood meals. The period 
would probably be even less for a species such as Psorophora confinnis 
due to its relatively short lifespan as compared to longer-lived mosqui-
toes such as Aedes sp. (16). 
According to the previously listed cri·teria for vector status only 
Psorophora confinnis and Aedes taeniorhynchus have been proven as likely 
vectors of the IB strains of VEE virus. Insufficient data are available 
at this time to unequivocally incriminate these species as vectors of 
epizoodemic VEE. Other probable vectors species according to habitat are 
as follows (115): 
(1) Permanent fresh water with vegetation. Mansonia indubitans 
and _tl. titillans. 
(2) Temporary fresh water pools, sunny and grassy. Psorophora 
conflnnis, f· discolor, and Aedes thelcter. 
(3) Coastal beaches, crab hole terrain. Deinocerites pseudes. 
(4) Coastal areas, brackish water, inland 80 to 110 kilometers. 
Aedes sollicitans and [1. taeniorhynchus. 
(5) Woodlands, fresh water, shady pools. Aedes scapularis. 
Although the role of mosquitoes as vectors of VEE virus is gradually 
being defined, the question of origin of epizoodemics of VEE remains 
unknown. Migratory birds have been considered to be a potential means 
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of transport of eastern and western equine encephalomyelitis viruses from 
one country to another, but few epizoodemic VEE virus isolations have 
been obtained from migratory birds to substantiate such a concept for 
VEE virus movement. According to Grayson (51) the only naturally-in-
fected, vlremic (epizoodemic VEE) bird reported has been a fledgling 
green heron (Butorldes virescens), also referred to as the striated heron 
(B. striatus). On the basis of that isolation Grayson and co-workers (51) 
inoculated 9 wild-caught, serologically negative green herons with 100 
suckling mouse lntraperitoneal lethal dose 50% (SMIPLD
50
) of the ~880, 
ID (endemic) strain of VEE virus.· The 9 birds were all viremic by the 
4th and 5th day postinoculatlon and were used for experimental trans-
mission studies with Deinocerites pseudes as the vector and golden 
hamsters as the recipient hosts~ Positive transmission was obtained 
indicating a possible role for the green heron in the movement of 
epizoodemlc VEE virus strains (IA, IB, IC) from country to country along 
the coastal areas as occurred in the epizoodemic that spread from 
Guatemala to the United States. Additional supporting evidence is that 
green herons commonly inhabit areas where the crab-hole-breeding 
Deinocerltes pseudes lives. 
To determine If rodents (57,63) could be involved in the main-
tenance of epizoodemlc VEE virus Zarate (135) and Walton (128) inoculated 
cotton rats (Sigmodon hlspidus) with epizoodemic strains IC and IB 
respectively. With 4 to 1000 plaque-forming units of virus administered 
subcutaneously Zarate obtained death patterns of 1 out of 5 and 3 out 
of 5 rats inoculated. Walton inoculated 3 weanling~· hispidus with 
14 
1000 SMICLD
50 
units of virus and had no survivors by 6 days post-
inoculation. The conflicting results of these two studies and the 
statistically small number of experimental animals indicate further 
studies in this area are needed to define the possible role rodents 
may have· in the maintenance of epizoodemic VEE virus. 
Fossaert (40), Franck (41) and Johnson (68) have likewise cited 
the possibility of epizoodemic virus residing in natural foci much 
as endemic strains of VEE are known to exist. Little evidence other 
than that of Grayson (51) and Walton (128) exists to substantiate such 
a hypothesis. 
Bats have also been proposed as a transport and maintenance mechanism 
for epizoodemic VEE by several workers (65). According to Baer, cited 
by Calisher (12), the Mexican freetail bat (Tadarida brasiliensls 
mexicana) cohabits with the vampire bat (Desmodus rotundus) and 
migrates hundreds of kilometers to the United States and to other 
regions. In August, 1970, Q. rotundus was found infected with the IB 
strain of VEE in the state of Oxaca, Mexico during an epizoodemic (27). 
Epizoodemic VEE virus has also been isolated in Ecuador from Q. rotundus 
in 1969 (51). 
Vampire bats subsist on a strict blood diet and frequently feed upon 
equines, consuming as much as 20 to 25 ml of blood per day. While feeding 
the bats may either ingest viremic blood or be bitten by infectious 
mosquitoes (27). Sanmartin (99) has fed heparinized viremic horse blood 
to Q. rotundus and has determined VEE virus to be present in the bat's 
oral cavity for!48 to 168 hours postinoculation. Transmission studies 
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have not yet been reported. However, after feeding vampire bats will 
often rest in hollow trees which may also serve as resting areas for 
mosquitoes. If those mosquitoes were also vector species they could 
then feed upon the resting, possibly viremic bats, and later become 
Infectious to exacerbate an epizoodemic of VEE (1,29). 
Another means of maintenance of epizoodemic strains of VEE virus 
that has been postulated is that of silent amplification. Groot (55) 
investigated various races of sheep from La Guijara, Colombia and found 
that they either developed a transient, minimal viremia or were not 
viremlc. However, all of the sheep exhibited serologic conversion from 
negative to positive. 
Goats have also been considered as possible silent amplifiers of VEE 
(57) but confirmatory data are not available at present (104). Serological 
surveys conducted during outbreaks of epizoodemic VEE have on the other 
hand shown a fairly high ratio of serologic conversion of domestic goats 
tested for VEE antibody by the hemagglutination-inhibition and serum-
neutral lzation tests. Bergold (7) found a high incidence of antibody in 
goats in Venezuela from 1962 to 1969. By the hemagglutination-inhibition 
tests 102 of 332 goats were positive at a serum dilution of 1:20. 
Eplzoodemic VEE virus was also obtained from a goat in Zulia, Venezuela 
over the eplzoodemlc period of 1968 to 1969. 
In an earlier publication, Sellers, et al. (110) described 
~ ~
hemagglutlnation-lnhibition and serum-neutralizing antibody titers in 
approximately 59 percent of 39 goats sampled from November, 1962 to 
January, 1964 in Venezuela. During epizoodemic virus activity in 
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Colombia from 1967 to 1968, Mackenzie (85) obtained an overall antibody 
incidence of 20 percent of 31 goats tested. Serum neutralization 
antibodies were also found in goats in Texas during the 1971 outbreak 
but detailed results are not yet available (94). 
The role of the dog as a silent amplifier has.been evaluated by 
several groups. Taber, et~· (118) infected beagles with the IA 
subtype of VEE virus and obtained adolescent (21-23 day old) mouse 
viremia titers ranging from 3.1 to 4.3 log 10 mouse IPLD50 per ml :0f 
viremic dog blood. Bivin, et al. (9) were able to transmit IA VEE virus --
to beagles with A· triseriatus mosquitoes which had been infected by 
the hanging-drop method. Davis, et al. (30) transmitted IA VEE virus --
from beagles to guinea pigs with A· triseriatus at viremia titers 
ranging from 3.7 to 6.0 log 10 adolescent (21-23 day old) mouse 1PLD50 
per ml of blood. However, work done by Sudla (115) indicates 
that the threshold for infection of A· triseriatus with the IB 
subtype of VEE virus is considerably higher than that indicated by the 
work of Davis, et~· (30) with the IA subtype of VEE virus. Based on 
the information available it does not seem likely that the dog would 
serve as a silent amplifier of IB VEE virus. 
Chamberlain (13) has proposed several areas which should be studied 
to elucidate the role of alteration of viral virulence in the sudden 
eruption of epizoodemic VEE in regions that previously were·11 free" of 
v I rus ac:tt vJ t·y. They a re as fo 1 I ows: 
(1) Passage in vertebrates with either higher or lower bo~y 
tempera.tures than the usual hosts. 
17 
(2) Incubation l.n vectors for either exceedingly long or very 
short periods. 
(3) Passage by the pharyngeal route (abnormal). 
(4) Reproductive organ infection and transmission by sexual 
contact. 
(5) Simultaneous infection of either mosquitoes or vertebrates 
with two strains of virus. 
Due to the high magnitude of viremia produced in man by VEE virus 
infection he is also subject to consideration as an amplification 
mechanism. Viremias in excess of 5.0 .log 10 SMICLD50 per ml of blood 
with a r,ange of 3,5 to 6.0 log10 per ml have been reported. Man i·s 
therefore a possible vehicle of virus movement but is of secondary 
importance when compared to the great mobility of equines (11,36,64,101, 
111, 126) • 
The movement of viremic equines has very likely played a major role 
in the dissemination of epizoodemic VEE in this day of modern, rapid 
transportation facilities (103,109,125). McConnell (86) has stated that 
about 50 percent of all equines infected by the epizoodemic virus will 
be clinically normal. Consequently, frantic owners have been known to 
ship their valuable horses out of regions where virus activity is prev-
alent and is responsible for dally reports of equine mortality and 
morbid l ty ( 120). Race horses have a 1 so been i ncr im i nated as 1ike1 y 
prospects due to their widespread travels from ranches to racetracks (93). 
Many factors point to equine movement as a major mode of spread of 
epizoodemic VEE virus but little specific evidence has been accumulated 
to date. 
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During the 1970 VEE outbreak in Central America an inactivated 
vaccine of poor quality was prepared in Nicaragua from IB VEE virus 
and distributed for use. Shortly thereafter breaks of the disease 
appeared to follow the path of the vaccine. When use of the preparation 
was suspended the equine cases of VEE immediately ceased (89). 
When 11 new11 epizoodemics of VEE appear the poor monitoring of equine 
deaths or complete lack of monitoring must be taken into consideration. 
The probability would seem to be great that epi zoodemic virus activity 
could have been occurring undetected in isolated regions of a country 
with a small but significant number of equine deaths (122) . The con-
current presence of endemic and epi zoodemic VEE viruses in a given 
region would present a partially immune equine population and would 
likely keep equine disease to a minimum. In this type of situation 
the epizoodemic virus activity would probably be detected only on the 
periphery of the endemic virus area resulting in a very low level or 
complete lack of virus activity being reported. 
The mechanism by which the epizoodemic virus overwinters in a given 
region is not known. On January 10, 1973, IB VEE virus was isolated 
from a pool of 50 Culiseta melanura in Xochimilco, Distrito Federal, 
Mexico, the first isolate of an overwintering study initiated in coop-
eration with the Communicable Disease Center (CDC) , Atlanta, Georg i a, by 
the Animal Health Department, Ministry of Agriculture and Livestock, 
Mexico (22). 
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Young (133) has proposed the phenomenon of recrudescence as a source 
of epidemics. Supportive evidence presented was the recurrence of 
clinical illness due to the IE subtype of VEE virus in a laboratory field 
worker one year after initial illness in a .region of Panama where IE VEE 
virus had never been isolated. 
Endemic (enzootic) VEE 
As listed in Table 1, antigenic groups ID, IE, II, III, and IV are 
not epizoodemic strains. Due to their focal nature involving primarily 
small rodents and possibly birds they have collectively been denoted as 
either endemic or enzootic VEE (4,18,19,46,47,66,72,74,95,107,108,134). 
Endemic virus strains have been isolated from 7 species of birds, while 
natural antibodies against the virus have been found in at least 23 avian 
species. In various laboratory trials all bird species studied developed 
low to moderate viremias, usually of 2 or more days• duration. In 
mosquito-transmission -experiments, some mosquitoes have become infected 
by feeding on birds with viremias as low as 2.6 log10 SMICLD50 of endemic 
VEE virus per ml. However, the presence of antibodies against endemic 
VEE virus in field-trapped birds has been highly variable. For given 
regions of endemic virus activity investigators have reported a complete 
lack of serological evidence in field-trapped birds while other groups 
have found a very high incidence of endemic VEE virus antibodies in 
their field-trapped birds from other endemic regions. Due to the marked 
discrepancies at present in this area of study, the role of birds in the 
maintenance of endemic VEE virus activity cannot be discounted as 
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insignificant (32,53,54,82,83). 
Endemic foci usually do not exceed one qua.rter of a square mile and 
are usually found in high rainfall areas with either a tropical or sub-
tropical climate (71). The foci may be in wooded regions and have often 
been found to be proximal to fresh-water swamps. The endemic virus cycle 
is mosquito-rodent-mosquito with occasional bird hosts comingled as noted 
earlier. Marsupials, bats, and raccoons have recently been incriminated 
in the cycle with small rodents (8,52,71,80,82,100,102,106). In Florida 
the mammals primarily involved in the cycle with Culex (Melanoconion) spp. 
appear to be the cotton rat (Sigmodon hispidus), the cotton mouse 
(Peromyscus gossypinus), the raccoon (Procyon lotor), and the opossum 
(Didelphis marsupialis)(8,15,82). See Table 5 for mammals involved in 
the maintenance of endemic VEE virus; 
A total of 38 species of mosquitoes in 14 genera and subgenera have 
been implicated in the transmission of endemic VEE virus (Table 6). 
Among them only 3 species have been reported in the literature as well-
substantiated vectors. Galindo (45) indicated that 2 species of mosquitoes 
proven to be efficient natural vectors of endemic VEE virus are Culex 
(Melanoconion) aikenii and.£. (tl.) portesi. Mosquito groups other than 
Culex (tl.) spp. are probably involved as secondary vectors in the natural 
transmission of endemic VEE virus. The third species which has been 
clearly implicated as a primary vector of endemic VEE is Culex (tl.) 
cedeci (15). These vector species would seem to possess a threshold for 
the endemic strains of VEE virus not unlike that of Culex tarsal is and 
western equine encephalomyelitis. Naturally-infected rodent species have 
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Table 5. Mammals considered to be involved in the maintenance of endemic 
VEE virus activity (47' 52, 53,54, 71,80,82,85, 1oo,102, 112, 113, 119, 
1 31) 
Species Virus Antibody 
isolation Hla CFb 
Rodent 
Cotton rat 
(Si smodon hisEidus} x x 
Terrestrial rice rat 
(Orzom)!S 1 at i ceEs) x x 
Rice rat 
(Orzom)!S Ealustris) x 
Spiny rat 
(Proechlm)!S semisEinosus} x x 
R Ice rat 
(Orzom)!S cali9nosus) x 
Common rat 
(Rattus rattus) x 
Thorny rat 
(HoElomys !J)!mnurus) x 
Spiny rat 
(Proechlm)!S !JU)!annensis or is) x x 
Rice rat 
(Orzomys caEito soeldii) x x 
Chisel-toothed kangaroo rat 
(DiEodom}:'.s microEs) x 
Cotton mouse 
(Perom)!SCUS !JOSS)!Einus) x 
Forest pocket mouse 
(Heterom)!S anomalus} x x 
Short-tailed cane mouse 
(Z)!9odontom)!S brevicauda) x x 
Deer mouse 
(Perom)!Scus maniculatus} x 
Western harvest mouse 
(Reithrodontom)!S me9alotis) x 
Mouse 
(Perom}:'.scus mexicanus) x 
aPresence of hemagglutination-inhibition antibodies. 
bComplement-fixation titers <?: 1: 16. 
cPresence of serum-neut ra 1 i zing an·t i bodies. 
SNc 
x 
x 
Table 5. (Continued) 
Species 
Marsupial 
Common opossum 
(Didelphis marsupial is) 
Philander opossum 
(Philander sp.) 
Woolly opossum 
(Cal uromys derb I.anus) 
Murlne opossum 
(Marmosa mitis) 
Bats 
--;ii;"t I be us 11 turatus 
Artibeus turp is 
Carollia subrufa 
Caroll la persplcillata 
Glossophaga sorcina 
Artibeus sp. 
Caroll la sp. 
Other.: 
Raccoon 
(Procyon 1 otor) 
Forest rabbit 
(Sylvilagus brasiliensis) 
Desert cottontail 
(Sylvilagus audubonii) 
Nuttal cottontail 
(Syl vi 1 agus nuttal 1 ii) 
Black-tailed jackrabbit 
(Lepus callfornicus) 
Paca 
(Agouti pa ca) 
Red squirrel 
(Sci urus granatens is) 
Vari~gated squirrel 
(Sciurus variegatoides) 
White-ta i 1 ed ante·l ope squ i rre 1 
(Citellus leucurus) 
Weasel 
(Mustella frenata) 
Kit fox 
(Vulpes macrotus) 
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Virus 
isolation Hla 
x x 
x x 
x x 
x x 
x 
x 
x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
Antibody 
CFb 
x 
x 
x 
x 
x 
SNc 
x 
I 
.I 
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Table 6. ·Mosquito species from which endemic VEE.viruses have been 
isolated (2,3,4,15,19,46,47,53172,74,105,113,131,135,136) 
Mosquito species 
Aedes angustivittatus 
Aedes atlantlcus 
Aedes scapularis 
Aedes serratus 
Aedes taenlorhynchus 
Anopheles aguasalis 
Anophe 1 es n lmbus 
Anopheles punctimacula 
Coguillettldla (Rhynchotaenla) 
albicosta 
Cogu i 11 ett id i a (Rhynchotaen i a) 
venezuelensls 
Culex corniger 
Culex coronator 
Culex nlgrlpalpus 
Culex guinguefasciatus 
Culex thriambus 
Culex (Eubonnea) accelerans 
Culex (Eubonnea) amazonensls 
Cu lex· (Me 1 anocon ion) a i ken ii 
Culex (Melanoconion) albinensis 
Culex (MelanoC:onion) cedeci 
Culex (Melanoconion) epanastasis 
Culex (Melanoconion) iolambdls 
Cu·lex (Melanoconion) opisthopus 
Culex (Melanocon.ion) portesi 
Cu·l ex (Me 1 anocon I on) sp i ss i pes 
Culex (Melanoconion) taeniopus 
Culex (Melanoconlon) thriambus 
Culex (Melanoconlon) vomerifer 
Culex (Melanoconion) ybarmls 
Deinocerltes pseudes 
Hemagogus mesodentatus 
Hemagogus (stegoconops) spegazzinli 
Country 
Brazil, Colombia, Ven~zuela 
Florida, U.S.A. 
Brazil, Mexico, Venezuela 
Brazil, Trinidad• Venezuela 
French Gu1ana; Florida, U.S.A. 
Brazil, Venezuela 
Braz i 1 
Colombia 
French Guiana 
Brazil, French Guiana, Trinidad 
Colombia 
Mexico 
Trinidad; Florida, U.S.A. 
Brazil, Colombia, Mexico, Panama 
Mexico 
Trinidad 
Trinidad 
Brazil, Colombia, Panama 
French Guiana 
Florida, U.S.A. 
Trinidad 
Mexico 
Mexico 
Brazil, French Guiana, Trinidad 
Trinidad 
Braz 11, French Guiana, Panama, Tr'in i.dad 
Mexico 
Brazil, Panama, Trinidad 
Trinidad 
Mexico, Panama 
Mexico 
Braz i 1 
Table 6. (Continued) 
Mosquito species 
Limatus durhami 
Llmatus fl avisetosus 
Mansonla fasciolata 
Mansonla titillans 
Psorophora ferox 
Sabeth i n.i sp. 
Wyeomyia medioalbipes 
Wyeomyla mltchelli 
Wyeoinyla (Dendromy.ia) occulta 
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Trinidad 
Trin.idad 
Mexico 
Trinidad 
Country 
Brazil, Mexico, Trinidad 
Braz i 1 
Trinidad 
Mexico 
French Guiana 
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been found to deve.lop vlremlas of 3.9 to 5.0 log 10 SMLD50 per ml of 
viremlc blood which persist from 4 to 5 days (45,71). Within endemic 
foci vector species have been found to be infected throughout the year 
(81). The presence of susceptible host spec.ies for maintenance of the 
virus is greatly facilitated by the average lifespan of 6 months for 
ground-dwelling rodents. Continuous virus activity is further assisted 
by the rodents' selective habit of breeding during the rainy season when 
large populations of the vector species are available (71). 
The fact that certain species of Culex of the subgenus Melanoconion 
such as f.. (tl.) portesi (71) will readily feed upon man presents tne 
potential of outbreaks of disease in man due to endemic VEE. Mosquito 
species in the genera Aedes, Anopheles, Deinocerites, Mansonia, and 
Psorophora are also known to feed avidly on equines and man .. (115). 
Since species of these genera are involved in the transmission of both 
endemic and ep.izoodemic strains of VEE virus, man is indeed a very 1 ikely 
candidate for disease in the presence of high virus activity in a given 
region. The first human case of VEE in the United States was due to 
endemic virus activity in Florida as reported by Ehrenkranz, et~· in 
1968 (35). More recently, however, the epizoodemic of VEE in Texas 
resulted in 88 laboratory-confirmed cases of human VEE with al 1 but 2 of 
the cases occurring in July, 1971 (24). 
The fluorescent antibody .test 
The swift spread of epizoodemic VEE and its high morbidity rate 
necessitates a rapid di agnost I c system. The fluorescent anti body test 
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(FAT) as developed by Coons, et~· (26) with subsequent modifications 
meets nearly all the requirements for a rapid, sensitive diagnostic 
test when performed in a tissue culture system. 
Several types of globulin separation and purification have been 
employed in preparation of fluorescent-antibody conjugates. The two 
more commonly employed techniques at present are 50 percent saturated 
ammonium sulfate precipitation and chromatographic separation of a 
ganvna-globul in-rich (lgG) fra.ction from hyperimmune sera. 
Coons,~~· orginally used fluorescein isocyanate for conjugation 
(26) but this compound has the disadvantages of being unstable and 
dangerous to prepare. The synthesis of fluorescein isothiocyanate (FITC) 
by Riggs, et~· in a more stable powder form has essentia.1 ly replaced the 
isocyanate compound for use in antibody conjugation (79,97 ,98). · The 
labeling of gamma globulin fractions with FITC can be done by either 
direct addition or by dialysis labeling. For direct conjugation FITC 
Is ordinarily added dropwise to the globulin fraction at a ratio that 
has varied from 1:20 (1 mg of FITC to 20 mg of protein) up to 1:200. 
Current literature indicates the most suitable range for optimal tagging 
to occur Is from 1:100 to 1:200 (44,132). 
Dialysis labeling, as described by Clark and Shepard (20), is gener-
ally considered to result in more uniform tagging of the antibody mole-
cules of the globulin preparation. Uniform labeling is also enhanced by 
the lack of albumin and any traces of macroglobulins (lgM). If these 
proteins are present their affinities for FITC are somewhat greater than 
that of the lgG In the globulin preparation resulting in less FITC-tagging 
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of lgG and a final conjugate with high background fluorescence and 
decreased specificity of fluorescence (88). 
Dilution, tissue powder adsorption, and anion-exchange column 
chromatographic purification of conjugates are three methods of removal 
or marked reduction of antibody molecules excessively tagged with FITC 
after unreacted FITC has been removed by either Sephadex G-25 1 chromato-
graphy or dialysis against a buffered saline solution. Dilution is one 
of the most widely used. techniques to reduce.nonspecific staining due 
to excessively-tagged antibody molecules and may readily be employed. 
with hlgh-titered conjugates. Tissue powder adsorption and anion-
exchange chromatography both reduce the antibody content of conjugates 
but they also result in a conjugate that is more specific in its staining 
characteristics. The· disadvantage of the tissue powder adsorption 
technique is that it can lead to bacterial contamination of the finished 
conjugate. The advantage of anion-exchange chromatography is that only 
optimally-labeled antibodies are left in the conjugate (28,31,49,87). 
1Pharmacia Ltd., Uppsala, Sweden. 
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MATERIALS AND METHODS 
Cell cultures 
To determine the optimal in vitro cell culture system for the iso-
lation and identification of the IB subtype of VEE virus a compar.ative 
propagation study was undertaken. Eight types of ceil cultures were 
analyzed for their ability to support growth of the virus with the 
production of visible cytopathic effects under a standard nutrient agar 
overlay. The cell cultures employed in this study were Vero African 
green monkey kidney cell line1, human amnion (FL) cell line1, baby hamster 
kidney (BHK-21) eel I 1 ine1, L eel I 1 ine1, goat kidney secondary cel 1 
culture2, bovine turbinate cell line2, horse kidney secondary cell culture2, 
and duck embryo fibroblast (DEF) primary cell culture. All cell cultures 
with the exception of the BHK-21 were grown and maintained with Gibco F-1S3 
medium supplemented with 10.0 ml L-glutamate and 10.0 ml sodium pyruvate 
per liter of medium plus serum as indicated below. The BHK-21 cell line 
was grown and maintained with Stoker's modification4 of Eagle's BME 3 which 
is the addition of tryptose phosphate broths to a concentration of 10 
percent of the final medium. Antibiotics employed in the two culture 
media were 10,000 IU penicillin, 0.13 g streptomycin, and 2.S mg nystatin 
per liter. For growth a 10 percent concentration of fetal calf serum 
1
As obtained from the American Type Culture Collection, Rockville, Md. 
2
Developed and maintained by Diagnostic Virology, APHIS, USDA, Ames, la. 
3Grand Island Biological Co., Grand Island, N.Y. 
4
stoker, M. 1962. Virology 1S:147-1S1. 
Soi fco Laboratories, Detro it,. Mi ch. 
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was used, and cells were maintained with medium containing 5 percent fetal 
calf serum with the exception of the BHK-21 cell culture which was main-
tained with the growth medium. 
For the comparative propagation study each of the 8 cell lines above 
was seeded into 25 cm2 Falcon flasks 1 and was inoculated when confluent 
with o.1 ml of a tenfold dilution of either cell culture or suckling mouse 
brain origin virus. The inoculated flasks wer.e placed in a 37C incubator 
for one hour to allow virus adsorption. They were then overlaid with 
5.0 ml of 1 percent Noble agar2 containing lx Earles 6553, 0.5 percent 
lactalbumin hydrolysate, 0.22 g' sodium bicarbonate per liter, 2 percent 
fetal calf serum, 3.3 ml of 1:100 neutral red per 200 ml, and 400 IU 
·penicillin, 200 µg streptomycin, and 100 µg nystatin per ml. Plaques 
were first counted after 48 hours incubation at 37C and again after an 
additional 24 hours incubation at 25C. The endpoint was calculated and 
expressed as the number of plaque-forming units per 0.1 ml (PFU/0.1 ml). 
Titers were then compared to virus titers obtained by suckling mouse 
inoculation to determine the relative sensitivity of each cell culture 
to IB VEE virus. 
Vi ruses 
The GJ9-1BJ strain of VEE virus was isolated from a pool of Psorophora 
confinnis mosquitoes collected near Parcelamiento Montufar, Guatemala, in 
1Falcon Plastics, Division of BioQuest, Los Angeles, Ca. 
2Difco Laboratories, Detroit, Mich. 
3Grand Island Biological Co., Grand Island, N. Y. 
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1969, during the course of an epizoodemic (62,116). Working stocks of 
this virus were prepared by inoculation of suckling mouse seed virus as 
supplied to Diagnostic Virology, APHIS, USDA, Ames, la., by CDC, Atlanta 
Ga., into suckling mice and two cell lines, Vero and goat esophagus 1• A 
0.5 ml quantity of a 1:100 dilution of 10 percent mouse brain suspension 
prepared in 0.01 M, pH 7.2, calcium-and magnesium-free phosphate-buffered 
saline containing 0.75 percent bovine serum albumin (BAPBS) was inoculated 
into each 75 cm2 Falcon flask of confluent cells. After a one hour 
adsorption period at 37C, 25 ml of maintenance medium containing one 
percent serum was pipetted into each flask and they were returned to a 
37C incubator. Fetal calf serum and normal goat serum were used in the 
respective cell cultures at a lower than normal concentration to allow 
use of the same stock viruses for tissue culture and goat inoculation 
studies. After a 48 hour incubation period the culture fluids were 
harvested as stock viruses and were maintained at -70C. 
The suckling mice inoculated for stock virus preparation were 
observed daily for signs of encephalitis. When 5 to 15 percent of the 
suckling mice were either prostrate, moribund, or dead the litters were 
harvested, A 10 percent suspension of the pooled mouse brains was 
prepared in BAPBS, divided.into 1.0 ml aliquots, and maintained at -70C as 
virus stock. 
1As obtained from the American Type Culture Collection, Rockville, Md. 
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Experimental animals 
Twelve domestic goats of mixed sex from 4 to 18 months of age were 
used in the experiments. Prior to purchase the goats were screened by 
the hemagglutination-inhibition test and were found to be negative for 
antibodies agai·nst eastern equine encephalomyl itis, western equine 
encephalomyelitis, and Venezuelan equine encephalomylitis viruses. They 
were housed in maximum biological security stalls with a filtered air 
intake and exhaust supply system that.is more than 99,6 percent effective 
in the removal of viral disease agents. 
Albino suckling mice, CF-1 strain, 2 to 4 days of age, obta.ined from 
Carworth Farms, Division of Becton, Dickinson and Co., New City, N. Y., 
were used for viremia assays and for titration of virus strains. The 
viruses were titrated in tenfold serial dilutions using 8 mice per dilu-
tion. Each mouse was inoculated intracerebrally with 0.02 ml of a given 
virus preparation and was then observed daily for 7 days. Moribund, 
prostrate, and dead mice were removed and stored at -70C until their 
brains could be processed for preparation of·complement fixation (CF) test 
antigen to confirm the presence of VEE virus in the affected mice. The 
log 10 SMICLD 50 per ml endpoint for each specimen was determined according 
to the method of Reed and Muench, cited by Lenette and Schmidt (79). 
Serology 
Hemagglutination-inhibition (HI) tests were performed by a microtiter 
modification of the method of Clarke and Casals (21) in twofold serum 
dilutions from 1:10. The test antigen was prepared from GJ9-1BJ VEE 
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virus infected mouse brains by sucrose acetone extraction. Ninety-six 
well, u-bottom plastic plates 1 with an arrangement of 8 by 12 wells were 
used for the test. A 0.25 percent suspension of goose red blood cells 
prepared in dextrose-gelatin-veronal buffer was employed for all hemagglu-
tination-inhibition tests. The mouse brain antigen mentioned above was 
then titrated for 4 to 8 hemagglutination units per 0.025 ml using a 0.2% 
bovalbumin, pH 6.o borate saline (BBS). Sera to be tested were likewise 
diluted in BBS for the HI test. Initially 0.05 ml of a 1:10 serum dilu-
tion was placed in the first well of the plate and 0.025 ml of BBS was 
dispensed in the succeeding wells. Twofold dilutions were then made with 
0.025 ml microdiluters 1, 0.025 ml of titrated antigen was placed in each 
well, and the test was incubated overnight at 4C. The following morning 
0.05 ml of a freshly prepared 0.25 percent suspension of goose red blood 
cells was added to each test well and the plate was briefly agitated for 
mixing of the test reagents. After one hour incubation at 37C the plate 
was read for the absence of hemagglutination, indicating a positive HI 
test. 
Serum virus neutralization (SN) testing was performed in 2 virus-
tissue culture systems. The GJ9-1BJ strain of VEE virus was used with the 
BHK-21 cell line and the TC-83 strain of VEE virus was used with DEF cells 
for titration of goat sera. All sera tested were heat-inactivated at 56C 
for twentymfoutes. The 0.2 ml al lquots of tenfold dilutions of sera being 
tested were aseptically dispensed into sterile 12 x 75 mm stoppered tubes 
1cooke Engineering Co., Alexandria, Virginia. 
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to each of which were added 0.2 ml of virus containing 120 to 200 PFU 
per 0.1 ml. The resultant mixtures were then agitated briefly and placed 
in a 37C waterbath for a one hour period of virus neutralization. At 
the end of the incubation period the tubes were removed and placed in a 
wet ice waterbath. One tenth ml of each mixture was then pipetted into 
2 25 cm2 Falcon flasks of either BHK-21 or DEF cells according to the 
strain of virus being used in that test. Following a one-hour period of 
virus adsorption at 37C, 5 ml of the Noble agar preparation previously 
described was dispensed into each flask. The flasks were then placed on 
a level surface at 25C for 15 to 25 minutes for agar solidification. When 
the agar had hardened the flasks were inverted and were incubated at 37C. 
After 48 hours the flasks were removed and the first plaque coun~ was made. 
A final count of plaques was made after 24 hours• incubation at 25C. The 
endpoint of a serum was that dilution producing at least a 90 percent 
plaque reduction. 
The complement fixation test was used to confirm that suckling mice 
employed for virus titrations which had been either moribund, prostrate, 
or dead at the time of harvest were infected with VEE virus. A 10 percent 
suspension of mouse brain was prepared in veronal buffer diluent (VBD), 
and was centrifuged at 10,000 rpm for 30 minutes. The supernatant fluid 
was retained as the 4x CF test antigen. The microtiter CF test' was 
performed with either VEE antiserum or mouse ascitic fluid employing 
dilutions of 1:8 through 1:256, a 1:20 dilution of unkown antigen, 7 
hemolytic units of complement, and sensitized sheep red blood cells. The 
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VEE ant I serum was di 1 uted in the p 1 ates with subsequent add! ti on of 
antigen and complement prior.to incubation overnight at 4C for complem~nt 
fixation. The following morning sensitized sheep red blood cells were 
added and the plate was incubated at 37C for 30 minutes, followed by 
centrifugation at approximately 250 g for 10 to 15 minutes to pack the 
remaining ghost and red blood cells. The test was read by comparing 
hemolysls against known color standards. From zero to 30 percent hemolysis 
was considered to be a positive test. Wells displaying greater than 30 
percent hemolysls were cons.idered to be negative. 
Sentinel study 
Six goats were inoculated intradermally with 1000 SMICLD 50 of goat 
esophagus cell culture origin GJ9-1BJ VEE virus (GEV). The 6 goats were 
divided into 2 groups with one noninfected goat per group to determine if 
contact transmission of GEV from goat to goat was possible. Blood samples 
were taken with and without heparin from the 8 goats from zero to 14 days 
postinoculation (DPI) for determination of viremia and for serologic assay. 
An additional aliquot of blood was obtained at zero DPI from each goat to 
provide normal goat serum for conjugation. Nasal, oral, and genitourinary 
swabs were also obtained 0-7 DPI to determine if VEE virus was shed by 
the infected goats. Serum samples were obtained from the 8 goats on a 
dally basis from 15-21 DPI and biweekly thereafter through 49 DPI. Rectal 
temperatures were recorded dally from 0-21 DPI. Goat viremia assay was 
done by BHK-21 plaque assay and intracerebral inoculation of suckling mice. 
Serologic responses were determined by HI and SN tests using viruses TC-83 
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and GJ9-1BJ. 
Antiserum production 
Two groups of goats were employed for the 2 immunization protocols. 
Two goats were inoculated subcutaneously (SC) with 1000 SMICLD50 of GEV 
In Freund's complete adjuvant 1 at o, 10, and 20 DPI. The 2 goats of the 
second group were inoculated SC with 1000 SMICLo
50 
of GEV, which was 
followed by 4 SC injections of the virus-adjuvant mixture described above 
at 8, 10, 12, and 18 DPl. Serum samples were obtained at o, 21, 30, 42, 
and 49 DPI for antibody assay. By 49 DPI the response of the 4 goats was 
not adequate {1:1000) by the SN test with virus GJ9-1BJ and the goats were 
subjected to challenge with 25,000 SMICLD50 of GEV intravenously (IV) at 
50 DPI. Serologic response was then monitored at 59, 63, 70, 72, and 80 
DPI to evaluate the 4 goats' response following challenge. The 2 goats 
of the first group displayed the greatest serological response by SN 
testing with vi~us GJ9-1BJ at 63 DPI.· Serum neutralization tests were 
done in the latter half of each week which meant that the 63 DPI results 
were not available until approximately 69 DPI. Serum harvest of the 2 
goats by exsanguination was consequently done at 72 DPI. The goats of the 
second group were exsanguinated with serum harvest at the termination of 
this study at 90 DPI. 
Seven of the 8 goats in the sentinel study were also used for the 
production of hyperimmune serum. One of the contact transmission goats 
was given 40,000 SMICLD50 of GEV IV at 50 DPI and rectal temperature was 
1Dlfco Laboratories, Detroit, Mich. 
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taken daily for 7 days. The 6 previously infected goats were challenged 
at 50 DPI with 25,000 SMICLD
50 
GEV given IV. Serologic monitoring was 
continued on a biweekly basis through 90 DPI. Exsanguination with serum 
harvest of the 7 goats was done at 70 (2 goats), 72 (1 goat), and 90 
(4 goats) DPI. 
VEE conj ugat_e preparation 
The serum of goat 152, which had the highest neutralizing-antibody 
titer to VEE using GJ9-1BJ virus, was selected for f.luorescent antibody 
(FA) conjugate preparation. The FA conjugate was prepared by 2 different 
techniques to assure that one of the conjugates would be of very high 
quality. The first technique used was the method described by Goldman (48). 
Four m.1 of the goat 152 serum were placed in an Amicon ultrafiltration 
ce11 1 equipped with a membrane designed to retain materials of greater 
than 100,000 molecular weight. Thirty-six ml of 0.1 M, pH 8 TRIS buffered 
saline were added to the cell and the cell was then placed on a magnetic 
stirrer set at a low speed to avoid denaturation of serum proteins. A 
pressure of 10 psi was applied to the cell for a period of approximately 
45 minutes to reduce the mixture to a volume of 4 ml and to remove more 
than 80 percent of the serum albumin originally present. The air pressure 
was then removed and the fi 1 tered protein so 1 ut ion was app 1 i ed to a 400 cc 
co 1 umn packed with Sephadex G-2002equi1 i brated with the TR IS buffer 1 i sted 
above. The gamma globulin (lgG) fraction was eluted overni9ht by reverse 
1
Scientific Systems Division, Amicon Corporation, Lexington, Mass. 
2Pharmacia Ltd., Uppsala, Sweden. 
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flow chromatography and was recorded with an ultraviolet scanning device1• 
The Lowry technique (84) was used to determine the protein concentration 
of the lgG fraction. The lgG fraction was then pressure dialyzed against 
0.05 M carbonate.-blcarbonate buffer, pH 9.0, to a 1.5 percent (15.0 mg 
protein per ml) concentration and was ·placed in 8.0 mm dialysis membrane 
tublng 2• A solution of fluorescein isothiocyanate3 (FITC) equal to 10 
times the volume of the lgG fraction was prepared in a 250 ml beaker 
with 0.05 M, pH 9.0 carbonate-bicarbonate buffer at an FITC concentration 
of 0.1 mg per ml of buffer. The dialysis tubing containing the lgG and a 
magnetic stirring bar were placed in the FITC solution at 4C. The beaker 
was covered with aluminum foll to prevent evaporation and was stirred 
slowly overnight with a magnetic mixer. 
The FITC-tagged lgG preparation was then removed from the dialysis 
tubing and was placed on a 2,0 x 20.0 cm column of Sephadex G-254 which 
was equilibrated with 0,01 M, pH 6.8 phosphate buffered saline (PBS). T~e 
conjugate was then eluted with the same buffer and was collected as a 
single colored band from the column. 
A 2.0 x 20.0 cm column of QAE-Sephadex4 (diethylaminoethyl-Sephadex) 
was prepared in 0.01 M, pH 6.8 PBS for purification of the conjugate. The 
conjugate was adsorbed to the column and was subsequently eluted by step-
wise addition of 0.1, 0.2, and 0.3 M NaCl to the PBS. Two column bed 
1 
instrumentat.ion Specialties Co., Lincoln, Nebraska. 
2 
Union Carbide Corporation, Films-Packaging Division, Chicago, 111. 
3 
The Sylvana Company, Milburn, N. J, Lot No. 1043. 
4 
Pharmacia, Ltd,, Uppsala, Sweden. 
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volumes, approximately 130 ml, were collected for each change of buffer. 
The fractions were then concentrated to the volume of the original lgG 
fraction by pressure dialysis, evaluated for fluorescent antibody activity, 
and stored at -20C. 
The second technique involved globulin precipitation with anvnonium 
sulfate, direct tagging with FITC,·and tissue powder adsorption of the 
conjugate (90). A 15.0 ml aliquot of antiserum from goat 152 was frac-
tionated at 4C by dropwise addition of an equal volume of 100 percent 
saturated ammonium sulfate solution to obtain a gamma-globulin precipitate. 
The resultant solution was stirred overnight at 4C and was then centrifuged 
at 250g for twenty minutes. The supernatant fluid was discarded and the 
precipitate was dissolved in distilled water to a volume of 15.0 ml. The 
protein solution was then reprecipltated twice at 4C over a 3-hour period 
as described earlier and the final precipitate was redissolved.in distilled 
water to a volume of 8.o ml. The resultant protein solution was diaiyzed 
against repeated changes of 0.85% NaCl solution at 4C until free of sulfate 
ions (so4) as determined by reacting a portion of the o.85% NaCl solution 
with a saturated solution of barium chloride. If so4 ions were present 
a white precipitate would have been observed. 
The protein concentration of the globulin solution was determined by 
the bi uret method (50) using a Co 1 eman spectrophotometer at 540 and 560 m µ.. 
The protein solution was then adjusted to a concentration of 1% by the 
addition of 0.1 M, pH 7.2 PBS (PBS'). The globulin solution was tagged 
! 
! 
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1 directly at a ratio of 1:20 (0.50 mg FITC per mg globulin). A solution 
of FITC equal to one-tenth the volume of the globulin solution was prepared 
with 0.5 M, pH 9.0 carbonate-bicarbonate buffer and was added dropwise to 
the globulin solutton with constant stirring. The FITC-globulin mixture 
was then stirred overnight at 4C with a magnetic mixer. 
A 2.0 x 20.0 cm column of Sephadex G-25 equilibrated with PBS' was 
used to remove FITC as described for the first conjugation preparation 
technique. The conjugate was next adsorbed with acetone-extracted rabbit 
liver powder. One g of liver powder was dissolved in 2.5 ml of PBS' for 
each 20 ml volume of conjugate. The rabbit liver powder slurry and con• 
jugate were then mixed overnight at 4C in a 250 ml beaker with the aid of 
a magnetic stirring bar. The following morning the mixture was centrifuged 
at 30,000 rpm for hour and the supernatant fluid was retained for further 
treatment. After dialysis against PBS• for 60 hours the conjugate was 
dispensed Into 1.0 dram screw-cap vials and maintained at -20C •. Conjugate 
staining specificity of two conjugate preparations was evaluated by staining 
VEE-virus-Infected BHK-21 cells. 
Normal conjugate preparation 
Four ml of pooled normal goat serum were fractionated by reverse flow 
Sephadex G-200 chromatography. The resulting lgG fraction was then con-
jugated according to the first technique described. To obtain a working 
dilution the normal conjugate was diluted to equal the intensity of 
1 The Sylvana Company, Milburn, N. J. Lot. No. 1043. 
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background fluorescence of the VEE conjugate when both conjugates were 
used to stain normal BHK-21 cell sheets. 
Specimens for examination by FAT 
In addition to FA endpoint titrations of suckling mouse GJ9-1BJ and 
DEF TC-83 VEE viruses, 10 percent tissue suspensions were examined by FAT. 
The VEE (GJ9-1BJ)-infected equine tissue suspensions were prepared from 
spleen, tonsil, liver, salivary gland, pancreas, adrenal gland, thxmus, 
lung, cerebellum, renal lymph nodes, splenic lymph nodes, mesenteric 
lymph nodes, and prescapular lymph nodes. 
Preparation of slides 
Baby hamster kidney (BHK-21) cells grown on coverslips in Leighton 
tubes were used for al I fluorescent antibody tests (FAT). Four tubes 
were employed for each test. When the cells were 85 to 100 percent 
confluent the growth medium was decanted and each tube was inoculated with 
0.1 ml of the material to be tested. The tubes were then returned to a 
37C incubator for a one hour period of adsorption. At that time a 1.25 ml 
aliquot of maintenance medium was dispensed Into each tube. Two tubes per 
test were decanted and rinsed twice with PBS' at 24 and 48 hours postin-
oculation. The cell monolayers were then fixed at 4C for a minimum of 
twenty-four hours by the addition of 10 ml of acetone to each tube. 
For staining the fixed BHK-21 coverslips were removed from their 
tubes and were allowed to air dry at 25C. Approximately 0.05 ml of VEE 
conjugate was applied to each coverslip as a thin film. The cells were 
then stained for a minimum of 20 minutes in a moist chamber at 37c. After 
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incubation the coversl ips were rinsed first in PBS and next in distil Jed 
water. After drying at 37C, the stained coverslips were mounted"cell 
surface down on 2.5 x 7.5 cm clear glass microscope slides with a mounting 
medium of 50% glycerin in PBS'. 
Two"conjugate specificity controls were employed for FAT, Normal 
conjugate was appJ ied to VEE-virus-infected eel I monolayers, and VEE 
conjugate was applied to normal cell monolayers. Eastern and western 
equine encephalomyelitis virus-infected cell monolayers were also stained 
with VEE conjugate to evaluate the conguate•s specificity of staining. 
Microscopy 
Incident-I ight fluorescence microscopy was used for examination of 
fluorescent antibody stained preparations (96). A Leitz Orthoplan 
microscope stand with a Leitz fluorescence vertical illuminator and 
mercury arc lamp (OSRAM HBO 200) was 
system: The excitation filters were 
equipped with 
1 1 2.0mm KG-1 
the following filter 
to block the infrared 
spectrum, 2 4.0mm BG-38 1 filters to absorb the red spectrum, 2 KP-4902 
short-wave pass-interference filters to obtain an excitation wavelength of 
490nm, and a 45 degree angle beam splitter TK-510 3 which reflected the 
490nm light beam through the objective to the specimen and allowed only 
I ight of"= 510nm to be transmitted back to the eyepieces. The barrier 
filter system included the beam splitter as described, ~ne TK-515 3 barrier 
1schott and Gen., Mainz, Germany. 
2Balzars, Vaduz, Lichtenstein. 
3E. Leitz, Wetzler, Germany. 
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1 'filter to pass light of :.:515nm, and one K-530. barrier passing light of 
::.: 530nm to the eyepieces. The 2 KP-490 filters combined with the TK510 
beam spl ltter ,produced a narrow-band filter system with both high. 
transmittance (::.: 80%) around 490nm and very low transmittance (:<: 0.0001%) 
around 525nm (96). 
Fluorescence photomicrography 
The Leitz Orthomat fully automatic camera system and Kodak high speed 
Ektachrome film2 (ASA rating of 160) were used to record FAT results. 
Exposure times ranged from 15 to 45 minutes. 
1 E. Leitz, Wetzlar, Germany. 
2Kodak, Rochester, N. Y. 
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RESULTS 
Comparative propagation of VEE virus 
Despite repeated attempts neither cytopathic effect (CPE) or 
plaqulng was obtained with the L cell line. Up to 5.0 x 105 SMICLD50 of 
the GJ9-1BJ strain of VEE virus were used in combination with a moist 
37C 5% co2 Incubation system as employed by Hardy and Brown (60). In a 
similar fashion, repeated attempts failed to produce either CPE or 
plaquing in goat kidney, human amnion (FL), bovine turbinate, and horse 
kidney cell cultures. 
The Vero African green monkey, duck embryo, and BHK-21 cell cultures 
were determined to be of approximately equal sensitivity in the propagation 
of virulent VEE virus. Cytopathic effects (CPE). were not readily apparent 
at 24 hours postinoculatlon under agar overlay. By 48 hours postinoculation 
CPE were evident and were somewhat different for each of the 3 cell 
cultures (Table 7). 
The CPE of the Vero .ce 11 1 i ne consisted of 70 to 90 percent cytolysis· 
of the plaque regions with rounding up of the remaining cells. Plaques 
became more difficult to detect between the 146th and 150th cell passages 
and the cells essentially lost their sensitivity to VEE-virus-induced CPE 
after 150 to 155 passages. 
Duck embryo cells seemed to be more resistant than the other 2 cell 
types to VEE-induced cytolysis. As few as 5 percent and a maximum of 60 
percent of the eel ls· within a plaque were lysed due to virus replication 
with 20 to 95 percent of the remaining cells rounding up. Rounded up and 
morphologically normal cells also had very fine cytoplasmic vacuoles 
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Table 7. Susceptibility of different cell types to GJ9-lBJ VEE virus 
Ce 11 Mean titer Suck I ing Cytopathic Mean plaque 
culturea effectsb culture 
Vero 
Duck embryo 
L eel I 
Goat kidney 
Human amnion 
Bovine turbinate 
BHK-21 
Horse k I dney 
a PFU/ml. 
cell 
6.4 x 108 
2.7 x 108 
Negative 
.Negative 
Negative 
Negative 
4. 3 x 10 8 
Negative 
mouse ICLD
50 
5 x 1010 48 hr, 70-90% 
5 x 1010 48 hr, 5-60% 
5 x 1010 ------
9.1 x 10 10 ------
9. 1 x 1010 ------
9. 1 x 1010 ------
5 x 1010 48 hr, 30-75% 
9. 1 x 1010 ------
bHours postlnoculation, % cells affected in the plaques. 
cDetermined during final 72 hr postinoculation plaque count. 
diameterc 
3.7mm 
2.7mm 
------
------
------
-------
3.3mm 
------
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present. 
The overall cytopathic effect on BHK-21 cells was not as marked as 
that se.en in Vero cells. Cytolysis varied from 10 to 45 percent of the 
plaque cell population with 5 to 75 percent rounding up. Cytoplasmic 
vacuolization was more marked in BHK-21 cells than that observed in duck 
embryo cells and was usually observed in greater than 30 percent of the 
plaque cells. 
The goat as a sentinel 
Serum neutralization (SN, TC-83 VEE virus) antibody titers of 1:10 
or greater were detected in of the 6 infected goats at 6 days postin-
oculation (DPI), 2 goats at 7 DPI, 5 goats at 8 DPI, and all goats by 9 
DPI. The SN titers in 5 of the 6 goats rose very rapidly and by the 
second day of response had increased from 1:10 to 1:100 (Figure 1). 
Serum-neutralization testing of the sera with GJ9-1BJ VEE virus did 
not detect a serological response until 8 DPI in 1 goat. By 10 DPI 5 of 
the 6 goats had 1: 10 titers. The 6th goat seroconverted by 15 DP I, was 
negative at 1: 10 for the next 3 days, and regained a 1: lO titer at 19 DPI. 
The 5 goats with 1:10 titers at 10 DPI responded in a serologically uniform 
manner for the remainder of the 45 day monitoring period (Figure 2). 
Maximal SN response with GJ9-1BJ virus was 1:100 in 1 goat as compared 
with TC-83 virus SN titers of 1:1600 in 3 goats, and 1:800 in the other 3 
goats of the group (Figure 1). 
Hemagglutination-inhibition (HI) titers did not appear until 7 DPI 
(1 goat). The maximal HI response was 1: 10,240 in 1 goat but another 
I 
Figure 1. Senti·nel goat study. TC-83·SN antibody titers of goats 
147, 152, 157, 158, 159, and· 161 between days 6 and 45 
postinoculation. Titers listed were the highest serum 
di 1 ut ion that produced at 1 east 90% p 1 aque reduction'. 
See Append i'x for specific titers. 
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Figure 2. Sentinel goat study. GJ9-1BJ SN antibody titers of goats 
147, 152, 157, 158, 159, and 161 between days 6 and 45 
postinoculati-on. Titers listed were the highest serum 
dilution that produced at least 90% plaque reduction. 
See Appendix for specific titers. 
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goat did not exceed a titer of 1:40 during the observation period (Figure 
3). The 2 contact 'transmission goats did not display detectable VEE viral 
antibodies by the 3 serological assay methods employed in this study. 
(See Appendix for titers by HI and SN). 
The goat as a silent amplifier of IB VEE virus 
Viremia was not detected by the plaque assay technique using BHK-21 
cells,, By suckling mouse inoculation 5 of the inoculated goats were 
found to be viremic for 1 to 3 days, viremia commencing between the 1st 
and 5th days postinoculation. One of these goats was viremic from day 1 
to day 3 postinoculation, another from day 2 to day 4, and a 3rd from day 
3 to day 4. One goat was viremic on days 3 and 5, and one goat was viremic 
only on day 4. Peak viremia did not exceed 4.08 log 10 SMICLD50 
per ml of serum. Respective SMICLo
50
tml of the sera are listed in Table 8. 
Oral, nasal, and genitourinary swabs obtained from day zero through day 7 
were negative for VEE virus by suckling mouse inoculation. 
Clinical evidence of disease in the domestic goat was lacking (Figure 
4) during the 21-day observation period with one exception. Goat number 
159 displayed an increased body temperature from day 2 through day 10, 
which peaked on day 5 at 41.1C (105.9F), The goat 1 s normal body temperature 
was 39.lC (102.3F) as determined from baseline data (Table 9), 
VEE antiserum production 
After intravenous challenge of the 3 groups of goats at 50 days post· 
inoculation, the maximum antibody titers as determined by the 3 tests were 
Figure 3. 
) 
Sentinel goat study. HI antibody titers of goats 147, 
152, 157, 158, 159 and 161 between days 6 and 45 
postinoculation. See Appendix for specific titers. 
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Table 8. Virus titers in serum of goats inoculated with GJ9•1BJ VEE virus 
Goat number Days Postinoculation Magnitude of Viremia 
(log 10 SMICLD50tml serum) 
147 1 4.08 
2 2.2 
3 2.2 
152 0-14 o.o 
157 3 < 1. 7 
4 < 1. 7 
158 4 1.95 
159 2 < 1.7 
3 3.27 
4 < 1. 7 
161 3 2. 36 
5 < 1. 7 
Table 9. Body temperatures of goat number 159 inoculated with IB VEE virus 
Days postinoculation Body temperature 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Normal body temperature 
C F 
39.2 
38.9 
39. 1 
39.6 
40.7 
41.1 
40.2 
40.2 
40.3 
40.9 
40.1 
38.7 
38.9 
39. 1 
102.5 
102.1 
io2.4 
103.2 
105.2 
105.9 
104.4 
1.04. 3 
104.6 
105,3 
104. 2 
101.6 
102. 1 
102.3 
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1:51,200 (SN~ TC-83, 7 of 12 goats), 1:1280 (SN, GJ9-1BJ 2 of 12 goats), 
and 1:64,000 (HI, 5 of 12 goats). See Appendix for listing of titers from 
zero through 90 days postinoculation. Serum from goat number 152 exan-
guinated at 72 DPI was selected for conjugation on the basis of a 
GJ9~1BJ SN titer of 1:1000. 
Conjugate evaluation 
After the QAE-Sephadex conjugate fractions had been concentrated by 
pressure dialysis they were examined for specific fluorescence on TC-83 
VEE virus-infected BHK-21 cells at 24 and 48 hours postinoculation. Only 
that fraction obtained by addition of 0.2 M NaCl demonstrated specific 
fluorescence. The fluorescence was finely granular in appearance and 
occurred only in the cytoplasm of infected cells (Figures 8, 10, and 11). 
Specificity of staining was evaluated by 2 methods. Baby hamster 
kidney (BHK-21) cells were infected with approximat~ly 103 PFU per ml 
of eastern equine encephalomyelitis or western equine encephalomyelitis 
viruses. At 24 hours postinoculation the infected cell cultures were 
fixed in acetone at 4C and were examined 1 day later with the conjugate. 
Cross-staining resulting in unwanted specific fluorescence did not occur 
(Figures 12 and 13). 
The second conjugate specificity parameter was the staining of normal 
BHK-21 cells 24 hours after they had been subjected to the same regimen as 
that employed for infecting cells. Nonspecific staining of normal cells 
was not observed (Figure 5). 
Ffgure 4. Absence of clinical signs in a domestic goat three days 
after infectfon with the GJ9-1BJ straf n of Venezuelan 
equine encephalomyelltis (VEE) virus. 
Figure 5. VEE conjugate applied to normal BHK-21 cell monolayer. 
Note absence of specific fluorescence. 125x 
r 
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Figure 6. VEE conjugate applied to GJ9-1BJ VEE-virus-infected BHK-21 
cell monolayer at 24 hours postinoculation. Note specific 
perinuclear and cytoplasmic fluoresence. 125x 
Figure 7. Normal conjugate applied to GJ9-1BJ VEE-virus-infected BHK-21 
cell monolayer at 24 hours postinoculation. Note absence of 
specific fluorescence. 125x 
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Ffgure 8. VEE conjugate applied to TC-83-VEE-virus-infected BHK-21 
cell monolayer at 24 hours posti nocul ation. Note specific, 
granular perlnuclear and cytoplasmic fluorescence. 500x 
Figure 9. VEE conjugate app lied to GJ9-1BJ-VEE-virus-infected BHK-21 
cell mono l ayer at 24 hours postinoculation. Note specific, 
granular perinuclear f luorescence. 1188x 
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Figure 10. VEE conjugate applied to TC-83-VEE-virus-infected BHK-21 
cell monolayer at 48 hours postinoculation. Note spec i fic 
cytoplasmic fluorescence of rounded up cells. 125x 
Figure 11. VEE conjugate applied to TC-83-VEE-virus-infected BHK-21 
cell monolayer at 48 hours postinoculation. Note specific, 
granular cytoplasmic fluorescence of rounded up cells. SOOx 
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Figure 12. 
Figure 13. 
VEE conjugate applied to western equine encephalomyelitis 
virus-infected BHK-21 cell monolayer at 24 hours postin-
oculation. Note absence of cross-sta ining. 125x 
VEE conjugate applied to eastern equine encephalomyelitis 
virus-infected BHK-21 cell monolayer at 24 hours postin-
oculatton. Note absence of cross-staining. 125x 
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When the direct 1 y-tagged conjugate prepa_rat ion was used to stain 
TC-83 virus-infected BHK-21 cells marked nonspecific staining was 
observed. Dilution of the conjugate beyond 1:8 was not feasible due to 
markedly diminished specific staining and at the 1:8 dilution the level 
of nonspecific fluorescence was not tolerable. On that basis further 
fluorescent antibody studies on VEE virus were done with Q.AE-Sephadex-
treated conjugate. 
The n<irma 1 -goat serum conjugate was prepared from Sephadex G-200 
fractionated lgG which was tagged with FITC and purified by Q.AE-
Sephadex column chromatography. The working dilution of 1:4 was 
derived by colll'arison of background fluorescence of both the normal 
and VEE conjugates when VEE virus-infected and normal BHK-21 cell 
monolayers were stained (Figures 5, 6, and 7). This conjugate 
was then employed as a specificity of staining control when conducting 
fluorescent antibody tests (FAT) on VEE virus-infected pony tissue 
suspensions. 
Comparison of sensitivity of FAT to suckling 
mouse inoculation for virus identification 
Initially the 2 stock virus preparations employed in this study were 
assaye_d by the fluorescent antibody test and intracerebral inoculation of 
suckling mice. Fluorescent antiboqy assay in BHK-21 cells was found to 
have approximately 1.0 log 10 per ml greater sensitivity. 
When 20 viremic pony tissues were tested by the 2 systems suckling 
mice were the most sensitive virus detection system. The threshold of 
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sensitivity of the fluorescent antibody test appeared to be between 1.6 
and 2.0 log
10 
SMICLD
50
/ml of 10 percent pony t.issue suspension. By 
FAT all tissue suspensions were positive by 24 hours postinoculation 
with the exception of 4 of 6 tissues in the 2.0 to 2.8 log10 SMICLD501ml 
virus titer range which were positive at 48 hours postinoculation. Two 
tissues with a titer of 1.6 log
10 
SMICLD
50
tml were negative at 24 and 48 
hours postlnoculatlon.by the fluorescent antibody test (Table 10). 
Table 10. Virus detection by the fluorescent antibody test (FAT) and by 
intracerebral inoculation of suckling mice 
Specimen 
. a Pony number 
TC-83 virus 
10% suckling 
mouse brain 
GJ9-1BJ virus 
Spleen 18 
Tons i 1 18 
Renal and splenlc 19 
lymph nodes 
Adrenal 19 
Salivary gland 19 
Liver 19 
Spleen 522 
Adrenal 522 
Mesenteric 522 
lymph node 
Liver 522 
Thymus 522 
Renal lymph 522 
node 
Pancreas 522 
Lung 524 
Spleen 524 
Thymus 526 
Mesenteric 526 
lymph node 
Cerebellum 529 
Prescapular 530 
lymph node 
Sp 1 een 530 
FATb Hours 
post inoculation 
> 9.0 24 
:i:10.o 24 
Pos. 48 
Pas, 24 
Pos, 24 
Pos. 24 
Pos, 24 
Pas. 24 
Pos. 24 
Pas. 48 
Pas. 24 
Pos. 48 
Pos. 24 
Pas. 24 
Pas. 24 
Neg. 48 
Pas. 24 
Pos. 24 
Pas. 24 
Neg. 48 
Pas. 24 
Pos. 48 
b SMI CLo50 
8.7 
9,5 
2. 1 
2. 1 
7. 1 
6.3 
6.o 
6.7 
3,5 
2.8 
5,7 
3,6 
5,2 
3.8 
4.o 
1. 6 
2.2 
5,3 
6.8 
1. 6 
4.3 
2.0 
with 
aTen percent tissue suspension in 0.753 BAPBS from ponies inoculated 
1000 SMI CLD50/ml GJ9-1BJ VEE virus intradermal ly. 
bLog10 per ml of inoculum; positive or negative (FAT). 
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DIS CUSS I ON 
The baby hamster kidney (BHK-21) cell line has been proven superior 
to either primary duck embryo or Vero African green monkey cell lines for 
titration of Venezuelan equine encephalomyelitis (VEE) virus. The Vero 
cell line is slightly more sensitive for the titration of the GJ9-1BJ 
strain of VEE virus but It lacks the potential for continuous serial 
passage that the BHK-21 line has as supplied from the American Type 
Culture Collection. Baby hamster kidney cells have been passaged in 
excess of 200 times at the National Animal Disease Laboratory, Ames, Iowa, 
without loss of sensitivity for VEE virus. In contrast, the Vero cell 
line is supplied at the 122nd passage level and has been found in this 
laboratory to lose its susceptibility to VEE virus between the 150th 
and 155th passage level. Earley, et~· (34) also did not find Vero cells 
to be sufficiently susceptible after 30 serial passages. Thus, the time 
saved by not having to restart the cell line from the 122nd passage level 
every three months more than justifies the choice of the BHK-21 cell line 
over the Vero cell 1 ine. 
Primary duck embryo cell cultures are slightly less sensitive for the 
detection of the epizoodemlc strain of VEE virus than BHK-21 cells. The 
mean VEE plaque diameter in the duck cells is also 1.0 mm less than in 
BHK-21 cells which makes enumeration of plaque-forming units more difficult. 
The BHK-21 cell line is thus the cell culture of choice of the 8 evaluated 
in this study. 
Experimental lnoC:u.lation of the goat with the minimal exposure of 
1000 SMICLD
50
, an average mosquito inoculum, revealed the goat to be·an 
excellent sentinel for VEE virus activity. The 6 inoculated goats 
developed titers greater than 1:10 as determined by hemagglutionation-
inhlbltlon (HI) and serum neutralization (SN) tests. Both persisted in 
excess of 40 days. In view of these findings the investigation of 
Dickerman, ~ ~· (33) would seem to have provided questionable information 
on the bovine as a possible sentinel species. In that· study 8 native HI 
and SN seronegative Colombian bovines were inoculated with a great excess 
of IB VEE virus, 7,1 log 10 primary chicken embryo cell. plaque-forming 
units (CEC-PFU), to "insure establishment of infection." The 7.1 log1·0 
CEC-PFU of virus would be roughly equivalent to 9 log 10 SMICLD50 • 
Considering an average mosquito inoculum of 1000 SMICLD
50
, approximately 
1,000,000 average IB VEE viremic mosquitoes would have had to feed upon 
' a single animal over a given period. In view of the Information obtai.ned 
herei.n with another domestic ruminant species, the goat, it would appear 
necessary to repeat that study with a lower inoculum of IB VEE virus. 
However, sufficient numbers of goats must be available to the 
potential vector to be able to detect VEE virus activity in an area. 
Hayes, et ~· (61) have demonstrated in a moquito host preference study 
in Hale County, Texas, that the predominant feeding habit of mosquitoes 
of the genera Aedes, Anopheles, Culiseta, and Psorophora is to feed 
upon mammalian species. Sudla (115) has stated that only Psorophora 
confinnis and Aedes taeniorhynchus have been proven as possible vectors 
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of the IB strain of VEE virus. He has also reported that 83 virus 
isolates compatible with VEE were obtained from Psorophora confinnis 
during the Texas epizoodemic (117). The bionomics off· confinnis have 
been shown to be associated with temporary fresh water pools located in 
sunny, grassy areas (115). Such areas can often be found in livestock 
pastures. Therefore, in regions where large goat populations are present 
the likelihood of the goat being a-sentinel of epizoodemic VEE virus 
activity would appear to be very good. 
Viremic goats on the other hand, do not offer a source of silent 
amplification of epizoodemic VEE virus according to the results of this 
study. Goat viremia did not exceed 4.08 log 10 SMICLD50
!ml, with a mean 
peak viremia of 2.67 log10 SMICLD50
/ml. The average viremia required to 
infect vector species of mosquitoes has been stated by Chamberlain (14, 
16) to be 5.0 log 10 SMICi.o50
/ml. Experimentally the Infection threshold 
of Psorophora confinnis has been found to be 4.9 to 5.2 log10 SMICLD50
/ml 
(115). Consequently, the goat is not likely to be an amplification 
mechanism of ep i zoodem i c VEE virus. 
Due to the excellent serologic response of the goats inoculated as 
sentinels they were hyperimmunized in an attempt to produce a more specific 
VEE antiserum than that which Was likely produced by the goats given 
multiple virus injections to stimulate antibody formation. The sero-
logical response of the 4 antiserum goats was no better than that of the 
goats of the sentinel study given only one injection of virus. The serum 
of goat number 152 was chosen for conjugate preparation because of its 
high.antibody titer as determined by the GJ9-1BJ SN test. Serological 
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testing by the other two techniques, HI and TC-83 SN later revealed an 
obvious lack of correlation of serum titers. The most plausible 
explanation of such differences is the presence of residual infectivity 
representing nonneutralized virus. Several workers have reported a 
similar phenomenon of nonneutralized virus in other virus-serum 
neutralization test systems. Ashe and Notkins (5), Bradish, et ~· (10), 
and Wall is and Melnick (127) have theorized residual infectivity to be 
due to the formation of infectious virus antibody complexes which resist 
further neutralization by antibody. Lafferty (78) used kinetic serum 
neutralization testing to show that residual infectivity was due to 
lack of antibody avidity. Fazekas 'de St. Groth, et~· (38) set forth 
the concept that residual infectivity was due to dissociation of the 
virus-antibody complex. Through extensive kinetic serum neutralization 
testing with VEE virus Hahon (58,59) has found that resid.ual infectivity 
of VEE virus is not due to dissociation of noninfective antigen-antibody 
complexes, to the presence of a genetically stable persistent viral 
subpopulation, or to the presence of free infectious ribonucleic acid in 
the virus preparation used for the serum neutralization test. His 
experiments with TC-'83 and Trinidad IA strains of VEE virus (58) have 
clearly demonstrated 2 factors contributing to VEE virus SN residual 
infectivity. One factor is the formation of viral aggregates of the virus 
preparation employed in the test system resulting in incomplete neutraliza-, 
tion. Hahon•s main concept was, however, that residual infectivity was 
due to the presence of sensitized VEE virions that were not neutralized '. 
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by the antiserum employed in the SN test. Supporting evidence for such a 
theory was obtained when neutralized suspensions were incubat~d at 35C 
for 1 hour with a 1: 10 dilution of anti-lgG serum. Addition of the anti-
lgG serum to a neutralized suspension yet containing 5.4 log10 units of 
residual virulent IA VEE virus infectivity further reduced viral in-
fectivity of the suspension by an additional 3.7 log10 units. Similar 
work has al!\o been done with lactic dehydrogenase virus and pol iovirus 
(73,91,92). 
A third component of Hahon's study was the determination of residual 
infectivity of Trinidad IA VEE virus as compared to the TC-83 attenuated 
strain. The percentage of original lnfectivity remaining after serum 
neutralization with a 1:50 dilution' of monkey VEE antiserum to Trinidad 
IA VEE virus was approximately 20% as compared to 2.2"/o residual activity 
for TC-83 VEE virus after 15 minutes incubation at 35C. Clearly, the low 
titers obtained with. the GJ9'-1BJ SN test as compared to those of the 
TC-83 SN tests would·appear to have been the result of residual infectivity 
of the virulent IS.strain of virus. The minor amount of residual infec-
tivity of the TC-83 SN test system made it possible to obtain good 
correlation with the VEE HI test. The information subsequently derived 
from the TC-83 SN and VEE HI tests indicated that several goats could 
have served as .a source for high-ti tered anti sera for conjugation. 
The fluorescent antibody conjugate prepared from the serum harvested 
from goat number 152 22 days after intravenous challenge With 25,000 
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SMICL0
50 
of GJ9-1BJ VEE v.irus was determined to b.e a highly specific 
preparation. Although antigenic interrelationships with eastern equine 
encephalomyel it is (EEE) and western equine encephalomyel it is (WEE) 
viruses were detected by EEE and WEE HI tests, they could not be demon-
strated with the fluorescent antibody test. 
Pooled normal goat serum was used to prepare a normal serum conjugate 
for use as a VEE conjugate specificity of staining controi. When the VEE 
conjugate was used on the BHK-21 cell line in a fluorescent antibody test, 
as little virus as 2.1 log10 SMICLD50
to.1 ml inoculum from GJ9-1BJ VEE-
virus-infected .pony tissue suspensions could be detected. If the Leighton 
tube inoculum would have been increased to 1.0 ml of tissue suspension· 
the sensitivity of the VEE fluorescent antibody test (FAT) would have 
likely been within 1 log10 dilution of that of intracerebral inoculation 
of 2- to 4-day-old suckling mice. The smaller inoculum was chosen for 
use in FAT to make it a more rapid diagnostic test. If the 1 arger 
inoculum·had been employed at least two washings with tissue culture 
medium would have been required to remove toxic tissue components from 
the BHK-21 monolayer after the 1 hour virus adsorption period, An 
additional factor to be considered was that of personnel safety. The 
use of a smaller inoculum with no washing of monolayers decreased the 
possibility of aerosol exposure to laboratory personnel. 
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SUMMARY 
The baby hamster kidney (BHK-21) cell line was shown to be superior 
to either primary duck embryo cells or Vero African green monkey cells 
as a host system for propagation of the epizoodemi·c strain, GJ9-1BJ, of 
Venezuelan equine. encephalomyelitis (VEE) virus. For that reason the 
BHK-21 cell line was chosen for evaluation of VEE fluorescent-antibody 
conjugates. 
Surveillance of possible VEE virus activity is of critical importance 
in avoidance of major epizoodemics. The goat has been evaluated as a 
sentinel for IB VEE virus activity in this study and was found to be a 
very sensitive sentinel animal. Six goats of mixed sex from 4 to ·18 
months of age when exposed to a single average mosquito inoculum of VEE 
.. 
. virus began to seroconvert within 6 days. Serological evaluation using 
the TC-83 and GJ9-1BJ serum neutralization tests and the VEE hemagglutina:.. 
tion-inhibition test showed that the 6 goats were seropositive for VEE 
antibody for 49 days. A minimum of VEE virus thus stimulated a very 
adequate serological response in the goat. 
Following challenge of the sentinel goats with 25,000 SMICLo
50 
of 
the GJ9-1BJ strain of VEE virus a suitable serum for conjugation was 
obtained. The VEE antiserum and normal goat serums were conjugated and 
evaluated for staining specificity in the BHK-21 cell line. No cross-
staining of the VEE conjugate with eastern equine encephalomyel it is virus 
or western equine encephalomyelltis virus was observed despite a 1:10 
cross reaction for both vi r.uses as detected by EEE and WEE hemagglutina-
tion-inhibition testing of the same serum. 
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The conjugate was assayed for sensitivity for the detection of VEE 
virus in cell cultures inoculated with equine tissue suspensions. The 
(BHK-21) cell line when combined· with a conjugate highly specific for VEE 
virus has been proven to be nearly as sensitive as intracerebral inoculation 
of the suckling mouse for the detection or identification of VEE virus. 
In a diagnostic sense the test can now be applied to routine screening of 
VEE diagnostic specimens. All negative specimens should then be tested in 
suckling mice by the intracerebral route for isolation of VEE virus not 
detected by the fluorescent antibody test. The fluorescent ant.ibody test· 
wou.ld be of greatest value in the event of an another outbreak of 
eplzoodemic VEE among the equidae of the United States. Large numbers 
of specimens likely to be positive for VEE virus would be encountered and 
a rapid, efficient technique such as the fluorescent antibody test would 
then be of critical importance. 
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APPENDIX 
TRIS Buffered Saline pH 8.0 
1. O. SM TR IS: 
Dissolve 60.57 g TRIS and 4.o g sodium azide (NaN3) in 200 ml triple-distilled, deionized water and q,s. to 
1000 ml. 
2. o.sM HCl: 
q.s. 42 ml of 11.9 M HCl to 1000 ml. 
3. Buffer preparation: 
a. two parts TRIS (133.3 ml) and one part HCI (66.6 ml) are mixed. 
b. add. 1.19 g of NaCl to 200 ml of TRIS buffered saline for a final 
NaCl concentration of O.lM. 
c. add 4.0 g NaN
3 
per liter of final buffer. 
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0.5 M Carbonate-Bicarbonate Buffer 
1 • Reagents required: 
a, 0.5 M solution of sodium bicarbonate (NaHC0 3
) 
b, 0.5 M solution of sodium carbonate (Na2co3) 
2. Mix 50 volumes reagent a with 4.5 volumes reagent b (pH should be 
9.0 when di luted 10 times in triple-disti 1 led water}, 
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0,1 M Phosphate-Buffered .Saline 
pH 7. 2: 
1. Prepare stock solutions a and b: 
a, 0.2 M monobasic sodium phosphate (NaH2Po4) Dissolve 27.8 g NaH 2Po4 in 1000 ml distilled water. 
b. 0.2 M dibaslc sodium phosphate (Na2HP04) Dissolve 53.65 g Na2HP04 · 7H2o in 1000 ml distilled water. 
2. Mix 28.0 ml of Solution a with 72.0 ml of solution b. Di 1 ute 
to a total of 200 ml with distilled water. 
pH 6.8: 
1. Prepare stock solutions a and b as· shown. 
2. Mix 51.0 ml of solution a with 49.0 ml of solution b. Di 1 ute 
to a total of 200 ml with distil led water. 
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Dextrose-Gelatin-Verona! Buffer 
1. Dissolve 0.58 g 5,5-diethyl barbiturate acid and 0.6 g gelatin in 
250 ml distilled water by heating. 
2. Combine the following reagents with solution 1: 
Sodium 5,5-diethyl-barbiturate 
CaC1 2 (anhydrous) 
MgS04 • 7H 20 
NaCl 
Dextrose 
3. q.s. to 1000 ml with distilled water. 
0.38 g 
0.02 g 
0.12 g 
8.50 g 
10.00 g 
\ 
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0.2% Bovalbumin, pH 6.o Borate Saline (BBS) 
1. Prepare pH 9, 0 borate saline as fol lows: 
a. mix 80 ml of 1.5 M NaCl, 100 ml of 0.5 M H3Bo3, and 24.0 ml of 1.0 M NaOH. 
b. q,s. to 1000 ml with distilled water. 
2, Add Cohn fraction V bovine serum albumin to borate saline (1) to 
a concentration of o.4%. 
3. Prepare 0.15 M NaCl-0.2 M Na 2HP04 as follows: 
a. mix 100 ml of 1.5 M NaCl and 100 ml of 2.0 M Na 2HP04 
b. q,s, to 1000 ml with distilled water. 
4. Prepare 0.15 M NaCJ-0.2 M NaH/0
4 
as fol lows: 
a, mix 100 ml of 1.5 M NaCl and 100 ml of 2.0 M NaH2Po4 
b. q.s. to 1000 ml with disti 1 led water. 
5, Mix 11 ml of solution 3 with 89 ml of solution 4. 
6. · Mix equal volumes of solutions 2 and 5, check pH, and BBS is then 
ready for use. 
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Veronal Buffer (VBD) 
1. Dissolve 42.5 g NaCl ahd 1.87 g sodium 5,5-diethyl-barbiturate · 
in 700 ml distilled water. 
2. Dissolve 2.875 g 5,5-diethyl barbiturate acid in 250 ml hot distilled 
water. 
3. Dissolve 20,333 g MgC1 2 (1.0 M) and 4.411 g CaC1 2 (0.3 M) in 1000 ml distil led water. 
4. 5 x VBD: 
a. Mix solutions 1 and 2 and cool to room temperature. 
b. Add 2.5 ml of solution 3 to a and q.s. to 1000 ml with distilled 
water. 
c. To use, di 1 ute 1: 5 and add 1.0 g gelatin per 1000 ml of final 
diluent. 
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Sentinel goat serological response·- Hla 
DPI b Goat Number 
147 152 157 158 159 161 
0 < 10 <10 <10 <10 <10 <10 
1 < 10 <10 <10 <10 <10 <10 
2 <10 <10 <10 <10 <10 <10 
3 <10 <10 <10 <10 <10 < 10 
4 <10 <10 <10 <10 <10 <10 
5 <10 <10 <10 <10 <10 <10 
6 <10 < 10 <10 <10 <10 <10 
7 20 <10 <10 <10 < 10 <10 
8 640 <10 10 <10 10 10 
9 5120 10 160 <10 20 20 
10 2560 20 320 10 80 160 
11 2560 20 320 20 320 320 
12 1280 40 640 40 320 320 
13 1280 40 640 320 320 320 
14 640 40 640 2560 2560 640 
15 2560 40 1280 2560 1280 640 
16 1280 40 2560 2560 640 320 
17 640 20 2560 1280 320 640 
18 1280 20 640 5120 640 1280 
19 640 20 640 5120 640 1280 
20 1280 20 320 2560 320 640 
21 5120 20 320 2560 320 64o 
24 2560 10 320 2560 320 1280 
30 5120 10 2560 5120 64o 2560 
35 10,240 <10 640 2560 1280 1280 
38 2560 < 10 . 640 1280 640 1280 
42 5120 <10 640 1280 1280 640 
45 1280 < 10 640 640 2560 2560 
aReciprocal of highest serum dilution giving inhibition of hemaggluti-
nation. 
bDay postinoculation. 
I 
I 
·.I 
! 
I 
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Sentinel goat serological response - SN(GJ9-1BJ)a 
DP lb Goat Number 
147 152 157 158 159 161 
0 <10 <10 < 10 <10 <10 <10 
1 <10 < 10 <10 < 10 <10 <10 
2 < 10 < 10 <10 <10 < 10 < 10 
3 <10 <10 <10 <10 < 10 <10 
4 <10 <10 < 10 < 10 <10 <10 
5 <10 <,10 < 10 <10 <10 <10 
6 <10 <10 <10 <10 < 10 <10 
7 <10 <10 <10 < 10 < 10 <10 
8 10 <10 <10 <10 <10 <10 
9 10 10 <10 <10 <10 < 10 
10 10 10 10 < 10 10 10 
11 10 10 10 <10 10 10 
12 10 10 10 <10 10 10 
13 10 10 10 <10 10 10 
14 10 10 10 <10 10 10 
15 10 < 10 10 10 10 10 
16 10 10 10 <10 10 10 
17 <10 <10 10 <10 <10 < 10 
18 <10 <10 10 <10 10 10 
19 <10 <10 10 10 10 10 
20 <10 <10 10 10 10 10 
21 <10 <10 10 10 10 <10 
24 <10' < 10 10 10 10 10 
30 10 <10 10 10 10 10 
35 <10 < 10 10 10 100 <10 
38 <10 <10 10 10 10 <10 
42 <10 <10 10 10 10 <10 
45 10 <10 10 10 100 <10 
aReciprocal of highest serum dilution that produced at least 90% plaque 
reduction. 
bDay postinoculation. 
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Sentinel goat serological response - SN(TC-83)a 
DP lb Goat Number 
147 152 157 158 159 161 
D <10 < 10 < 10 < 10 <10 < 10 
1 <10 <10 <10 <10 <10 < 10 
2 < 10 < 10 < 10 <10 <10 <JO 
3 <10 < 10 < 10 .. <10 < 10 <10 
4 <10 <10 <10 <10 <10 < 10 
5 <10 <10 < 10 <10 <10 <10 
6 10 <10 < 10 <10 <10 <10 
7 100 <10 10 <10 < 10 <10 
8 800 10 100 <10 10 10 
9 1600 100 400 10 10 100 
10 1600 400 400 10 100 200 
11 1600 400 400 100 100 800 
12 1600 800 1600 400 200 800 
13 1600 400 1600 800 400 800 
14 800 800 1600 800 400 800 
15 800 800 800 800 400 800 
16 800 800 1600 1600 800 800 
17 800 400 1600 800 400 800 
18 400 200 800 800 200 800 
19 400 200 400 800 200 800 
20 200 200 400 800 400 800 
21 400 200 800 1600 200 800 
24 800 100 400 800 200 400 
30 800 200 400 800 200 800 
35 800 100 400 800 4oo 1600 
38 400 100 400 800 800 800 
42 800 100 200 Boo 800 400 
45 400 100 400 800 800 . 800 
aReciprocal of highest serum di.lution that produced at least 90% plaque 
reduction. 
bDay postinoculation. 
B5 
Antiserum production in the goat. Serological response. 
Goat Number a Day Postinoculation 
Hernrnagglutination-inhibition b 
0 21 30 42 
149 <10 Boo 1600 Boo 
150 <10 -.. <10 4oo 400 
155 <10 Boo Boo 200 
156 < 10 200 200 100 
Serum Neutralization (GJ9-1BJ)c 
149 < 10 100 10 <10 
150 <10 <10 10 10 
155 <10 10 100 <10 
156 < 10 10 10 10 
Serum Neutralization (TC-B3) c 
149 <10 Boo 1600 8oci 
150 <10 <10 400 400 
155 <10 800 800 200 
156 <10 200 200 100 
aGroup 1 = 149, 150. Group 2 = 155, 156. 
bExpressed as reciprocal of highest serum dilution giving inhibition 
of hemagglutination. 
cReciprocal of highest serum dilution that produced at least 90% 
plaque reduction. 
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Serological response following hyperimmunization - Hla 
DP lb Goat Number 
147 149 150 152 155 156 
49 640 320 160 < 10 320 40 
52 64Ci 20 
56 32,000 32,000 
59 32,000 32,000 32,000 64,ooo 32,000 32,000 
63 32,000 32,000 16,000 
66 16,000 32,000 
70 4000 64,ooo 16,000 64,ooo 16, 000 16,000 
72 64,000 4000 16,000 
73 4000 
77 4Cioo 
80 2000 4000 4000 
84 2000 
87 2000 
90 2000 20 . 2000 
DPI Goat Number 
157 158 159 160c 161 162 
49 320 320 320 < 10 320 <10 
52 160 320 320 <10 160 <10 
56 32,000 8000 64,ooo 10 64,ooo < 10 
59 32,000 8000 64,ooo 640 16,000 <10 
63 64,ooo 8000 32,000 1280 16,000 < 10 
66 32,000 8000 32,000 2560 16,000 <10 
70 32,000 8000 8000 1000 16,000 < 10 
72 <10 
73 16,.000 4000 1280 <10 
77 32,000 2000 5120 <10 
80 16,000 2000 2560 <10 
84 8000 2000 2560 <10 
87 2560 <10 
90 8000 2000 2560 <10 
aReciprocal of highest serum dilution giving inhibition of 
hemagglutination. 
b Day postinoculation. 
c . 
GJ9-1BJ VEE administered 40,000 SMICLD O goat esophagus orig in virus 
intravenously\on da9 50. 
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Serological response following hyperimmunization - SN,GJ9-1BJ 
a 
DP lb Goat Number 
147 149 150 152 155 156 157 158 159 16oc 161 
4g <10 10 100 <10 <10 10 10 10 100 <10 <10 
52 <10 80 < 10 <10 100 <10 <10 
56 80 1280 320 1280 1280 100 160 
59 320 1280 640 1280 160 320 320 320 1280 640 640 
63 10 640 100 1280 100 320 100 160 1280 320 160 
66 4o 1280 160 80 1280 160 320 
70 80 640 320 1280 40 160 20 80 640 100 100 
72 100 160 1000 
73 20 40 100 100 
77 40 80 100 100 
80 40 20 100 80 100 20 
84 4o 40 40 
87 4o 4o 40 
90 40 20 80 80 4o 10 
aReciprocal of highest serum dilution that produced at least 90% 
plaque reduction. 
bDay postinoculation. 
162 
< 10 
< 10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
c4o,ooo SMICLD 0 goat esophagus origin GJ9-1BJ VEE virus administered intravenously on da~ 50. 
BB 
Serological response following hyperimmunization - SN TC-B3a 
DP lb Goat Number 
147 149 150 152 155 156 
49 400 400 200 100 400 100 
52 1600 200 
56 51,200 51,200 
59 51,200 51,200 12,Boo 25,600 51,200 12,Boo 
63 51,200 51,200 12,BOO 12,Boo 51,200· 12,Boo 
66 51,200 12,Boo 
70 25,600 25,600 6400 12,Boo 12,BOO 12,Boo 
72 51,200 12,Boo 12,BOO 
73 51,200 
77 25,600 
Bo 12,BOO 12,Boo 3200 
B4 12,BOO 
B7 12,Boo 
90 12,BOO 12,BOO 1600 
DPI Goat Number 
157 15B 159 16oc 161 162 
49 200 4oo Boo 10 400 <10 
52 400 Boo Boo 10 Boo <10 
56 51,200 51,200 51, 200 Boo 51,200 <10 
59 51,200 51,200 51,200 Boo 51,200 <10 
63 51,200 51,200 51,200 Boo 51,200 <10 
66 51,200 25,600 51,200 200 25,600 <10 
70 12,Boo 6400 51,200 200 25,600 <10 
72 <10 
73 51,200 12,BOO 200 <10 
77 25,600 6400 200 <10 
Bo 12,BOO 12,Boo 200 <10 
B4 12,Boo 6400 200 <10 
B7 6400 200 <10 
90 12,Boo 6400 200 <10 
aReciprocal of highest serum dilution that produced at least 90% 
plaque reduction. Final titer recorded on day of exanguination with serum 
harvest. 
bDay postinoculatlon. 
c4o,ooo SMICLD 
0 
goat 
intravenously on da? 50. esophagus origin GJ9-1BJ VEE virus administered 
l. 
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